Lecanemab for Patients With Early Alzheimer Disease
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.7230
Abstract: Key Points Question The US Food and Drug Administration has promoted innovation in clinical trial design via the bayesian approach; does that make clinical trials more efficient? Findings In this bayesian analysis of a randomized… read more here.
Keywords: patients early; alzheimer disease; lecanemab patients; early alzheimer ... See more keywords